Home | Business News | Browse by Publication | C | Chain Drug Review | June, 2004

Chain Drug Review

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Total result: 89 articles

Page 1 of 2 Next page of results

Drug chains in enviable position in O-T-Cs.
June 21, 2004

Chain drug stocks continue rebound.
June 21, 2004

An entrepreneurial spirit reigns.
June 21, 2004

MSI offers insights into Rx practice.
June 21, 2004

Vigilance against counterfeit drugs a priority.
June 21, 2004

Wrigley flexes muscle in children's arena.
June 21, 2004

CDMA harnesses buying power of 8,000 stores.
June 21, 2004

Puig builds portfolio with four major launches.
June 21, 2004

Active solves dilemma of excess inventory.
June 21, 2004

Zooth is in forefront of 'retro' license trend.
June 21, 2004

Pharmacy is part of the community.
June 21, 2004

Shoppers want choice; retailers give it to them.
June 21, 2004

Pharmacies try to help seniors through maze.
June 21, 2004

New front in Medicaid rate battle.
June 21, 2004

Supermarketers have their own special headaches.
June 21, 2004

Advanced Medical Optics aims to raise profile.
June 21, 2004

Ansell touts high-quality products, services.
June 21, 2004

RFID and the pharmaceutical supply chain.
June 21, 2004

Stratmar makes 'retailtainment' its speciality.
June 21, 2004

Western Research 'shakes up' laxative category.
June 21, 2004

Carbolite fosters growth of low-carb lifestyle.
June 21, 2004

Maybelline breakthroughs come fast, furious.
June 21, 2004

Dialogue.
June 21, 2004

Paul Murphy, executive vice president, Revlon Inc.
June 21, 2004

Checkpoint on cutting edge of retail technology.
June 21, 2004

E.T. Browne builds on heritage in skin, hair care.
June 21, 2004

Woodward products make skin, nails healthier.
June 21, 2004

Neutrogena builds on tradition of innovation.
June 21, 2004

Elizabeth Arden ups support for drug channel.
June 21, 2004

McNeil's Splenda 'a phenomenal growth engine'.
June 21, 2004

Similasan market strategy avoids me-too status.
June 21, 2004

Merix focuses on building RELEEV brand.
June 21, 2004

Smart Brands 'fills need, generates excitement'.
June 21, 2004

PTS Labs serves the best interest of children.
June 21, 2004

Health Products a force in branded, PL fields.
June 21, 2004

Church & Dwight builds robust brand portfolio.
June 21, 2004

Hyland's offers 'natural remedies that work'.
June 21, 2004

L'eggs products offer new benefits, solutions.
June 21, 2004

Anda bridges gap between suppliers, retailers.
June 21, 2004

Unilever demonstrates that less can be more.
June 21, 2004

Continental extends reach into men's hair care.
June 21, 2004

Boots brings skin care lines to U.S. market.
June 21, 2004

Retailers react to the changing face of beauty.
June 21, 2004

Glamour lets readers judge best new H&BAs.
June 21, 2004

Sophisticated data gives insights into what's shaping the H&BA market.
June 21, 2004

Ideavillage a power in 'as seen on TV' category.
June 21, 2004

CVS is ready to put stamp on California.
June 21, 2004

Longs settles lawsuit; profits to be impacted.
June 21, 2004

Ex-Rite Aid exec gets probation, not prison.
June 21, 2004

Kids Care line 'safe, efficacious, functional'.
June 21, 2004

Beauty Beat markets line 'that really works'.
June 21, 2004

New owner out to change perception of Jane.
June 21, 2004

At AquaCell it's about much more than water.
June 21, 2004

With 30 years of experience, Windmill delivers.
June 21, 2004

Consumer-mandated innovation fuels Novartis.
June 21, 2004

Improved service, new products enable Clay-Park to triple sales.
June 07, 2004

Generic access.
June 07, 2004

Drugs not always first choice.
June 07, 2004

As category's scope grows, so does opportunity.
June 07, 2004

Teens with diabetes learn to 'Dream Big'.
June 07, 2004

Targeted marketing now a must.
June 07, 2004

PL items can raise margins.
June 07, 2004

Mylan posts record sales and earnings.
June 07, 2004

Generics use yields savings in Michigan.
June 07, 2004

Andrx to sell Genpharm's version of Paxil.
June 07, 2004

FluMist repurchase O.K.'d.
June 07, 2004

Senate lauded for passage of project BioShield Act.
June 07, 2004

D-T-C ad changes sought.
June 07, 2004

Canada proposes "morning after" access.
June 07, 2004

FDA reiterates curbs on ties with industry.
June 07, 2004

Senate GOP proposes health plan.
June 07, 2004

N.J. focuses on drugmakers.
June 07, 2004

Psychologists given prescription authority.
June 07, 2004

Pfizer settles marketing case.
June 07, 2004

Propulsid award vacated.
June 07, 2004

More articles from Chain Drug Review...